New regulation for the control of ASF in the EU
March 17, 2023/ Official Journal of the European Union/ European Union.
https://eur-lex.europa.eu
The Official Journal of the European Union has published Commission Implementing Regulation (EU) 2023/594, of 16 March 2023, laying down special disease control measures for African swine fever and repealing Implementing Regulation (EU) 2021/605.
Since the date of adoption of Implementing Regulation (EU) 2021/605, the epidemiological situation in the Union has evolved and new experience and knowledge on the epidemiology of African swine fever has been gathered in the Member States. Therefore, it is appropriate to review and adapt the current special disease control measures for African swine fever laid down in that Implementing Regulation taking account of those developments and in order to prevent the spread of that disease in the Union.
Changes include:
- Lay down specific prohibitions and risk mitigating measures for the movements of consignments of kept porcine animals within those restricted zones and expand the scope of the current special disease control measures laid down in Union rules accordingly.
- Following confirmation of an outbreak of African swine fever in kept or wild porcine animals in a previously disease-free Member State or zone, the concerned areas are identified at Union level as protection and surveillance zones or, in the case of wild porcine animals, as an infected zone and listed in Annex II to this Regulation with the duration of that regionalisation.
- In order to ensure a territorial continuity of restricted zones for kept or wild porcine animals, in specific situations and taking account of the risk assessment, where relevant, it should also be possible to list previously disease-free zones after the confirmation of an outbreak of African swine fever as restricted zones II or III in Annex I to this Regulation instead of listing these zones in Annex II hereto.
- Movements of consignments of kept porcine animals and products thereof to other Member States and to third countries should not be authorised from the infected zones listed in Annex II hereto.